University of Utah medical researchers made an important step in diagnosing autism through diffusion tensor imaging, an MR technique that could help healthcare providers identify the problem much earlier in children and lead to improved treatment and outcomes for those with the disorder.
University of Utah medical researchers made an important step in diagnosing autism through diffusion tensor imaging, an MR technique that could help healthcare providers identify the problem much earlier in children and lead to improved treatment and outcomes for those with the disorder.
In a study published in Cerebral Cortex online, researchers led by neuroradiologist Dr. Jeffery Anderson a University of Utah assistant professor of radiology, used MRI to identify areas where the left and right hemispheres of the brains of autism patients do not properly communicate with one another. Those areas are in “hot spots” associated with functions such as motor skills, attention, facial recognition, and social functioning–behaviors that are abnormal in autism. Scans of people without the disorder did not show the same deficits.
“We know the two hemispheres must work together for many brain functions,” Anderson said. “We used MRI to look at the strength of these connections from one side to the other in autism patients.”
Other than increased brain size in young children with autism, there are no major structural differences between the brains of people with autism and those who do not have the disorder. It has been long believed more profound differences could be discovered by studying how regions in the brain communicate with each other.
The study, and other work University of Utah researchers are doing, using diffusion tensor imaging reveals important information about autism. The advances highlight this strategy as a potential diagnostic tool, so patients could be screened objectively, quickly, and early on when interventions are most successful. The advances also show the power of MRI to help scientists better understand and potentially better treat autism at all ages.
“We still don’t know precisely what’s going on in the brain in autism,” said Dr. Janet Lainhart, an associate professor of psychiatry and pediatrics at the University of Utah, and the study’s principal investigator. “This work adds an important piece of information to the autism puzzle. It adds evidence of functional impairment in brain connectivity in autism and brings us a step closer to a better understanding of this disorder. When you understand it at a biological level, you can envision how the disorder develops, what are the factors that cause it, and how can we change it. ”
An increasing number of studies have shown abnormalities in connectivity in autism, but this study is one of the first of its kind to characterize functional connectivity abnormalities in the entire brain using MRI rather than in a few specific pathways. The research involved about 80 autism patients between the ages of 10-35 and took about a year and a half to complete. The results will be added to an existing autism study following 100 patients over time.
“The longitudinal imaging data and associated knowledge gathered forms a unique resource that doesn’t exist anywhere else in the world,” said Lainhart.
In addition to someday using MRI as a diagnostic tool for autism, researchers also hope to use the data to biologically describe different subtypes of autism.
“This is a complex disorder that doesn’t just fall into one category,” Lainhart said. “We hope the information can lead us to characterizing different types of autism that may have different symptoms or prognoses that will allow us to identify the best treatment for each affected individual.”
The collaborative autism imaging research group led by Lainhart is working together to develop methods to use brain imaging to better understand autism and improve the lives of affected individuals. It includes researchers in the departments of psychiatry, radiology, and pediatrics, the Neurosciences Program, the Scientific Computing and Imaging Institute, and The Brain Institute at the University of Utah, as well as collaborators at Brigham Young University, the University of Wisconsin, and Harvard University.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.